BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7653100)

  • 1. Dominance of a single Epstein-Barr virus strain in SCID-mouse tumors induced by injection of peripheral blood mononuclear cells from healthy human donors.
    Menin C; Ometto L; Veronesi A; Montagna M; Coppola V; Veronese ML; Indraccolo S; Bruni L; Corneo B; Amadori A
    Virus Res; 1995 May; 36(2-3):215-31. PubMed ID: 7653100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and Hu-SCID mouse tumours.
    Menin C; Ometto L; Veronesi A; Roncella S; Corneo B; Montagna M; Coppola V; Veronese ML; Indraccolo S; Amadori A; De Rossi A; Ferrarini M; Chieco-Bianchi L; D'Andrea E
    Mol Cell Probes; 1996 Dec; 10(6):453-61. PubMed ID: 9025083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
    Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
    Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
    Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
    J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
    Miller WE; Edwards RH; Walling DM; Raab-Traub N
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.
    Sample J; Kieff EF; Kieff ED
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2741-6. PubMed ID: 7931160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.
    Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y
    J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
    Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
    Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
    Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.
    Dardari R; Khyatti M; Cordeiro P; Odda M; ElGueddari B; Hassar M; Menezes J
    Int J Cancer; 2006 Apr; 118(8):1977-83. PubMed ID: 16287066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
    Itakura O; Kikuta H
    Nihon Rinsho; 1997 Feb; 55(2):467-72. PubMed ID: 9046842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.
    Erickson KD; Berger C; Coffin WF; Schiff E; Walling DM; Martin JM
    J Virol; 2003 Apr; 77(7):4415-22. PubMed ID: 12634399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
    Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
    J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
    Sung NS; Edwards RH; Seillier-Moiseiwitsch F; Perkins AG; Zeng Y; Raab-Traub N
    Int J Cancer; 1998 Apr; 76(2):207-15. PubMed ID: 9537582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.
    Garnier JL; Cooper NR; Cannon MJ
    Am J Pathol; 1993 Feb; 142(2):353-8. PubMed ID: 7679547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
    Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
    Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
    Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
    Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice.
    Abedi MR; Linde A; Christensson B; Mackett M; Hammarström L; Smith CI
    Int J Cancer; 1997 May; 71(4):624-9. PubMed ID: 9178818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.